WO1996010998B1 - Anti-acne method and composition - Google Patents

Anti-acne method and composition

Info

Publication number
WO1996010998B1
WO1996010998B1 PCT/US1994/011502 US9411502W WO9610998B1 WO 1996010998 B1 WO1996010998 B1 WO 1996010998B1 US 9411502 W US9411502 W US 9411502W WO 9610998 B1 WO9610998 B1 WO 9610998B1
Authority
WO
WIPO (PCT)
Prior art keywords
composition according
acne
peroxide
composition
antibiotic
Prior art date
Application number
PCT/US1994/011502
Other languages
French (fr)
Other versions
WO1996010998A1 (en
Filing date
Publication date
Priority to US08/225,409 priority Critical patent/US5446028A/en
Priority claimed from US08/225,409 external-priority patent/US5446028A/en
Application filed filed Critical
Priority to US08/776,005 priority patent/US5767098A/en
Priority to AU79740/94A priority patent/AU7974094A/en
Priority to PCT/US1994/011502 priority patent/WO1996010998A1/en
Publication of WO1996010998A1 publication Critical patent/WO1996010998A1/en
Publication of WO1996010998B1 publication Critical patent/WO1996010998B1/en

Links

Abstract

Composition and method for the treatment of acne including a peroxide and an antibiotic selected from the lincomycin or tetracycline family of antibiotics.

Claims

AMENDED CLAIMS[received by the International Bureau on 14 March 1995 (14.03.95); new claims 9 and 10 added; remaining claims unchanged (1 page)]
1. A composition for the topical treatment of acne comprising a peroxide and antibiotic of the lincomycin family, said composition being substantially stable at a temperature of 50°C for a period of thirty (30) days.
2. The composition according to claim 1 , wherein the peroxide comprises benzoyl peroxide, and the antibiotic comprises clindamycin or a pharmaceutically acceptable salt or ester thereof.
3. The composition according to claim 2 comprising about 1 to about 30 weight percent benzoyl peroxide and about 0.01 to about 5 weight percent clindamycin or a pharmaceutically acceptable salt or ester thereof.
4. An aqueous gel composition for the topical treatment of acne comprising a peroxide, an antibiotic of the lincomycin family and a surfactant.
5. The aqueous gel composition according to claim 4, wherein the peroxide comprises benzoyl peroxide, the antibiotic comprises clindamycin and the surfactant comprises dioctyl sodium sulfocuccinate.
6. The aqueous gel composition according to claim 5, comprising about 0.5 to about 3 weight percent of dioctyl sodium sulfocuccinate.
7. A method for treating acne comprising topical administration to a patient afflicted with acne of an effective amount of the composition according to claim 1.
8. A method for treating acne comprising topical administration to a patient afflicted with acne of an effective amount of the composition according to claim 4.
9. A composition according to claim 1 , having a pH of about 4.6 to about 5.7.
10. A composition according to claim 4, having a pH of about 4.6 to about 5.7.
PCT/US1994/011502 1985-12-12 1994-10-11 Anti-acne method and composition WO1996010998A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US08/225,409 US5446028A (en) 1985-12-12 1994-04-08 Anti-acne method and composition
US08/776,005 US5767098A (en) 1985-12-12 1994-10-11 Anti-acne method and composition
AU79740/94A AU7974094A (en) 1994-10-11 1994-10-11 Anti-acne method and composition
PCT/US1994/011502 WO1996010998A1 (en) 1994-04-08 1994-10-11 Anti-acne method and composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/225,409 US5446028A (en) 1985-12-12 1994-04-08 Anti-acne method and composition
PCT/US1994/011502 WO1996010998A1 (en) 1994-04-08 1994-10-11 Anti-acne method and composition

Publications (2)

Publication Number Publication Date
WO1996010998A1 WO1996010998A1 (en) 1996-04-18
WO1996010998B1 true WO1996010998B1 (en) 1996-07-11

Family

ID=26788447

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1994/011502 WO1996010998A1 (en) 1985-12-12 1994-10-11 Anti-acne method and composition

Country Status (2)

Country Link
US (2) US5446028A (en)
WO (1) WO1996010998A1 (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028105A (en) * 1989-04-06 2000-02-22 Nigra; Thomas P. Topical drug delivery composition and method
US6117843A (en) * 1992-02-18 2000-09-12 Lloyd J. Baroody Compositions for the treatment of acne containing clindamycin and benzoyl peroxide
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US6221847B1 (en) 1996-09-13 2001-04-24 Clemson University Composition and method for treating bacterial infection
EP0927023B1 (en) * 1996-09-13 2004-11-03 Clemson University Composition for treating acne
US5912255A (en) * 1998-02-27 1999-06-15 Bussell; Letantia Topical fluoroquinolone antibiotics combined with benzoyl peroxide
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US6774100B2 (en) 2000-12-06 2004-08-10 Imaginative Research Associates, Inc. Anhydrous creams, lotions and gels
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
US6462025B2 (en) 2000-12-12 2002-10-08 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US7326420B2 (en) * 2001-03-06 2008-02-05 Burkhart Craig G Benzoyl peroxide compositions having increased potency
US6737070B1 (en) * 2001-03-06 2004-05-18 Craig N. Burkhart Methods of increasing the efficacy of peroxides
US20040043946A1 (en) * 2002-09-03 2004-03-04 Popp Karl F. Topical formulations for treatment of skin disorders
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
GB0301577D0 (en) * 2003-01-23 2003-02-26 Edko Pazarlama Tanitim Ltd Sti Topical pharmaceutical and/or cosmetic dispense systems
CA2513773C (en) * 2003-01-24 2013-03-26 Connetics Australia Pty Ltd Clindamycin phosphate foam
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US20050025817A1 (en) * 2003-07-03 2005-02-03 Bhatia Kuljit S. Delivery system for topical medications
US7776355B2 (en) * 2003-07-03 2010-08-17 Medics Pharmaceutical Corporation Delivery system for topical medications
US20070086977A1 (en) * 2003-12-22 2007-04-19 Stockel Richard F Method of treating dermatological conditions
US20050136024A1 (en) * 2003-12-22 2005-06-23 Stockel Richard F. Dermatological compositions
US20070244195A1 (en) * 2004-05-18 2007-10-18 Burkhart Craig N Treatment methods with peroxides and tertiary amines
US7479289B2 (en) * 2004-07-02 2009-01-20 Medicis Pharmaceutical Corporation Stable cleanser compositions containing sulfur
US7655682B2 (en) 2004-07-02 2010-02-02 Medicis Pharmaceutical Corporation Triple anti-irritant composition
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
EP1814560A2 (en) * 2004-11-19 2007-08-08 Aventis Pharmaceuticals, Inc. Antibiotic compounds, compositions and medical uses
EP1898898A2 (en) * 2005-03-10 2008-03-19 Jr Chem, LLC Benzoyl peroxide compositions and methods of use
WO2006099192A2 (en) 2005-03-10 2006-09-21 Jr Chem, Llc Stable organic peroxide compositions
US20090306023A1 (en) * 2005-06-29 2009-12-10 Ramirez Jose E Stable organic peroxide compositions
WO2007005471A2 (en) * 2005-06-29 2007-01-11 Jr Chem, Llc Stable organic peroxide compositions
AR054805A1 (en) * 2005-06-29 2007-07-18 Stiefel Laboratories TOPICAL COMPOSITIONS FOR SKIN TREATMENT
US7556820B2 (en) 2005-06-29 2009-07-07 Jr Chem, Llc Stable organic peroxide compositions
CA2617681C (en) * 2005-08-02 2015-02-03 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
US9107844B2 (en) * 2006-02-03 2015-08-18 Stiefel Laboratories Inc. Topical skin treating compositions
PL2206494T3 (en) 2006-03-31 2016-06-30 Stiefel Res Australia Pty Ltd Foamable suspension gel
US20100047357A1 (en) * 2007-02-01 2010-02-25 Sol-Gel Technologies Ltd. Compositions for topical application comprising a peroxide and retinoid
EA018275B1 (en) * 2007-02-01 2013-06-28 Сол-Джел Текнолоджиз Лтд. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
WO2008097850A1 (en) * 2007-02-02 2008-08-14 Warner Chilcott Company, Inc. Tretracycline compositions for topical administration
US20080188446A1 (en) * 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
US20080287373A1 (en) * 2007-05-17 2008-11-20 Popp Karl F Topical skin treating kits
US20090217924A1 (en) * 2008-02-28 2009-09-03 Gregory William Pearson Treatment systems and methods
EP2280718B1 (en) * 2008-04-01 2016-07-27 Lucas Meyer Cosmetics Canada Inc. Extracts from plants of the tsuga genus and uses thereof in the treatment of inflammation, irritation and/or infection
WO2009148584A1 (en) 2008-06-05 2009-12-10 Dow Pharmaceutical Sciences, Inc. Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
GB0911213D0 (en) 2009-06-30 2009-08-12 Syntopix Group Plc Formulation
JP5753089B2 (en) * 2008-10-20 2015-07-22 ドウ ファーマシューティカル サイエンシーズ、インク. Method for obtaining a stable dispersion of benzoyl peroxide
CA2753290A1 (en) 2009-07-02 2011-01-06 Sanofi Topical skin treatment kits
US9744150B2 (en) * 2009-10-21 2017-08-29 Dow Pharmaceutical Sciences Inc. Suspension containing micronized benzoyl peroxide
US20110236503A1 (en) * 2010-03-23 2011-09-29 Cosmalabs International, Llc Topical Skincare Composition
EP2817069A1 (en) 2012-02-21 2014-12-31 Ranbaxy Laboratories Limited Composition comprising a retinoid and benzoyl peroxide
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
US20180235924A1 (en) 2015-08-20 2018-08-23 Sol-Gel Technologies Ltd. Compositions for topical application comprising benzoyl peroxide and adapalene
KR101986177B1 (en) 2016-10-31 2019-06-05 (주)동구바이오제약 Pharmaceutical composition with improved bioavailability for acne treatment

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798053A (en) * 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
US2699054A (en) * 1953-10-09 1955-01-11 Lloyd H Conover Tetracycline
US2712517A (en) * 1954-03-03 1955-07-05 Bristol Lab Inc Production of tetracycline and substituted tetracyclines
US2886505A (en) * 1956-04-20 1959-05-12 Singleton Company Plating apparatus
US3019173A (en) * 1956-06-04 1962-01-30 American Cyanamid Co Method for preparing tetracycline
US3005023A (en) * 1957-04-05 1961-10-17 American Cyanamid Co Production of tetracycline
US3301899A (en) * 1963-11-27 1967-01-31 Bristol Myers Co Purification of tetracycline
US3475407A (en) * 1967-12-22 1969-10-28 Upjohn Co Process for preparing 7(r)- and 7(s)-halolincomycins
US3535422A (en) * 1968-03-11 1970-10-20 Stiefel Laboratories Stable benzoyl peroxide composition
US3509127A (en) * 1968-04-30 1970-04-28 Upjohn Co Isologs of lincomycins and process for preparing the same
US3544551A (en) * 1968-04-30 1970-12-01 Upjohn Co 7-mercapto-7-deoxylincomycins and process for preparing the same
US3513155A (en) * 1968-05-07 1970-05-19 Upjohn Co Sulfoxides of 7-halo-7-deoxylincomycins and process
US3952099A (en) * 1973-03-13 1976-04-20 The Procter & Gamble Company Dermatological compositions
US4056611A (en) * 1973-04-16 1977-11-01 Stiefel Laboratories, Inc. Therapeutic composition
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4132781A (en) * 1974-12-19 1979-01-02 Nelson Research & Development Company Method for treatment of acne
BE843140A (en) * 1975-06-19 1976-10-18 AAZACYCLOALCAN-2-ONES 1-SUBSTITUTES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AS EXCIPIENTS
US3989816A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US3989815A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Novel N-bis-azacyclopentan-2-onyl alkanes
US3991203A (en) * 1975-06-19 1976-11-09 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4497794A (en) * 1980-12-08 1985-02-05 Dermik Laboratories, Inc. Erythromycin/benzoyl peroxide composition for the treatment of acne
FR2378523A1 (en) * 1977-01-26 1978-08-25 Grupper Charles ACNE TREATMENT MEDICINE
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
US4387107A (en) * 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US4444762A (en) * 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
LU85111A1 (en) * 1983-12-01 1985-09-12 Oreal ANTI-ACNETIC COMPOSITION BASED ON BENZOYL PEROXIDE AND AT LEAST ONE SOLAR FILTER

Similar Documents

Publication Publication Date Title
WO1996010998B1 (en) Anti-acne method and composition
AU586286B2 (en) Pharmaceutical and dietary composition
CA2258606A1 (en) Crystal form ii of clarithromycin
BR9502016A (en) Propiophenone derivative process for the preparation of the same anti-diabetes agent pharmaceutical composition and use of said derivative
CA2107669A1 (en) Preparation for treating wounds and hemorrhoides
CA2148928A1 (en) Pharmacologically active pyridine derivatives and processes for the preparation thereof
CA2263972A1 (en) 6-o-substituted ketolides having antibacterial activity
ES2196092T3 (en) LIPOSOMIC ANTIBACTERIAL COMPOSITION, OF LOW RIGIDITY.
CA2145826A1 (en) Lipopeptide derivatives, a process for their preparation and their use
AU2002222296A1 (en) Macrolide antibiotics
CA2351429A1 (en) 13-membered azalides and their use as antibiotic agents
PT876388E (en) TRYCYCLIC ERYTHROMYCIN DERIVATIVES
AU3902299A (en) Methods of treating microbial infection and therapeutic formulations therefor
AU1377995A (en) A method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
CA2267309A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
IE831920L (en) 2,4-diamino-5-piperazinyl pyrimidines
EP0329008A3 (en) Cephalosporinderivatives and process for its preparation
AU4540096A (en) Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
AU2998797A (en) 6-o-substituted erythromycin compounds and method for making same
WO1998006265A3 (en) Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine
AU4785896A (en) Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
AU5697690A (en) Crystalline cephem acid addition salts and processes for their preparation
AU695190B2 (en) Substance FA-70D, process for producing the same, and uses thereof
IE43125L (en) Aminoglycoside derivative
AU4950597A (en) Composition containing chitosan